Zymo Research

Zymo Research is a well-established, privately-held provider of essential tools and services for modern molecular biology and genomics. The company operates primarily as a platform and services business, offering a comprehensive suite of products for sample stabilization, DNA/RNA purification, epigenetics (notably bisulfite conversion), microbiome profiling, and NGS workflows, complemented by contract sequencing and bioinformatics services. With a strong focus on enabling research in genetics, genomics, and diagnostics, Zymo has built a reputation for reliable, automation-friendly technologies and has strategically positioned itself in high-growth areas like wastewater surveillance and microbiome-based diagnostics. Its business model is commercial and revenue-generating, supported by direct sales, OEM partnerships, and a global distributor network.

Integrated ecosystem for molecular biology workflows, including ambient-temperature nucleic acid stabilization (DNA/RNA Shield), bisulfite conversion for epigenetics, unbiased microbiome DNA extraction (ZymoBIOMICS), and automation-ready NGS library prep.

Zymo competes in niche segments against giants like Thermo Fisher, Qiagen, and Illumina, as well as specialized players. It differentiates through user-friendly, automation-integrated kits, a strong reputation in epigenetics, and a vertically integrated offering from sample to sequencing data via its services.